Browse Category

NASDAQ:NRIX News 8 December 2025 - 15 December 2025

Cathie Wood Sells $40M in Tesla, Keeps Cutting Iridium, and Adds Nurix: What ARK Invest’s Latest Trades Signal on Dec. 15, 2025

Cathie Wood Sells $40M in Tesla, Keeps Cutting Iridium, and Adds Nurix: What ARK Invest’s Latest Trades Signal on Dec. 15, 2025

Cathie Wood’s ARK Invest is heading into mid-December with a familiar playbook: rotate aggressively, publish the receipts, and keep investors guessing about what “disruptive innovation” looks like in a market that’s re-pricing risk. On Monday, December 15, 2025, the broader backdrop is a market trying to steady itself after a bruising tech-led pullback and renewed debate over whether parts of…
Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

Biggest Stock Losers Today in the U.S. (Dec. 10, 2025): DYN, SLM, KTB, WAY and More Slide as Fed Decision Looms

U.S. stocks are trading in a holding pattern on Wednesday, December 10, 2025, as Wall Street waits for the Federal Reserve’s final interest‑rate decision of the year. Index moves are modest, but beneath the surface a cluster of mid‑cap names is posting double‑digit percentage declines, led by Dyne Therapeutics (DYN), SLM Corp (SLM), Kontoor Brands (KTB) and Waystar Holding (WAY).…
Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics (NRIX) Stock Soars on ASH 2025 Trial Data: Latest News, Analyst Forecasts and Outlook as of December 8, 2025

Nurix Therapeutics, Inc. (NASDAQ: NRIX) is back in the spotlight. On December 8, 2025, the biotech stock surged roughly 20% intraday after the company released new Phase 1 data for its Bruton’s tyrosine kinase (BTK) degrader bexobrutideg (NX‑5948) in blood cancers at the American Society of Hematology (ASH) Annual Meeting and scheduled a corporate webcast for this evening. MarketBeat The…

Stock Market Today

  • Rs 1.75 Lakh Crore Selloff Hits Indian IT Stocks Amid AI Fears
    February 4, 2026, 1:35 AM EST. Indian IT stocks faced a historic Rs 1.9 lakh crore market value drop on Wednesday, driven by fears that artificial intelligence (AI) advancements could disrupt traditional software and IT services. Shares of Infosys and Mphasis fell over 7%, while others like LTIMindtree, Wipro, and TCS declined between 4% and 6%. The selloff extended globally, with Nasdaq tech stocks losing around $300 billion. The catalyst was AI developer Anthropic's launch of tools automating sectors like legal and marketing, heightening concerns about AI replacing conventional IT roles. Experts warn this 'SaaSpocalypse' risks shrinking profit margins and undermining competitive positions, prompting downgrades of major software firms. Investors are reassessing valuations amid uncertainty over AI's impact on IT services growth and profitability.
Go toTop